Gainers
- ACADIA Pharmaceuticals ACAD shares moved upwards by 17.05% to $31.71 during Monday's after-market session. At the close, ACADIA Pharmaceuticals's trading volume reached 837.1K shares. This is 57.76% of its average volume over the last 100 days. The company's market cap stands at $5.0 billion.
- Evofem Biosciences EVFM shares increased by 7.9% to $0.4. Today's trading volume for this security ended up closing at 367.9K shares, which is 12.64 percent of its average volume over the last 100 days. The company's market cap stands at $65.2 million.
- BioDelivery Sciences Intl BDSI shares rose 6.66% to $3.52. BioDelivery Sciences Intl's trading volume hit 273.2K shares by close, accounting for 24.16% of its average volume over the last 100 days. The company's market cap stands at $347.7 million.
- Pasithea Therapeutics KTTA shares increased by 4.16% to $1.5. Trading volume for this security closed at 224.0K, accounting for 8.57% of its average full-day volume over the last 100 days. The company's market cap stands at $32.8 million.
- TRACON Pharmaceuticals TCON shares increased by 3.09% to $2.83. The company's market cap stands at $55.0 million.
- Hoth Therapeutics HOTH shares increased by 3.06% to $0.77. The market value of their outstanding shares is at $18.5 million.
Losers
- CytomX Therapeutics CTMX shares declined by 22.33% to $5.01 during Monday's after-market session. Today's trading volume for this security ended up closing at 83.3K shares, which is 10.22 percent of its average volume over the last 100 days. The company's market cap stands at $326.8 million.
- Statera BioPharma STAB stock decreased by 4.1% to $2.11. The market value of their outstanding shares is at $67.7 million.
- Artelo Biosciences ARTL stock declined by 3.59% to $0.56. The market value of their outstanding shares is at $23.6 million.
- InVivo Therapeutics Hldg NVIV shares fell 3.39% to $0.53. The market value of their outstanding shares is at $18.1 million.
- AquaBounty Technologies AQB shares declined by 3.06% to $2.22. The market value of their outstanding shares is at $157.6 million.
- Reshape Lifesciences RSLS stock declined by 2.53% to $1.93. Today's trading volume for this security ended up closing at 85.5K shares, which is 5.79 percent of its average volume over the last 100 days. The company's market cap stands at $6.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AQBAquaBounty Technologies Inc
$0.724224.6%
ARTLArtelo Biosciences Inc
$0.98002.08%
CTMXCytomX Therapeutics Inc
$1.08-0.92%
EVFMEvofem Biosciences Inc
$0.00910-2.15%
HOTHHoth Therapeutics Inc
$0.7900-3.36%
KTTAPasithea Therapeutics Corp
$2.652.32%
RSLSReshape Lifesciences Inc
$4.628.45%
STABStatera BioPharma Inc
$0.0330-63.8%
TCONTRACON Pharmaceuticals Inc
$0.0295-8.39%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in